Turku, Finland

Fredrik Ollila

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Fredrik Ollila: Innovator in Biocompatible Materials

Introduction

Fredrik Ollila is a notable inventor based in Turku, Finland. He has made significant contributions to the field of biocompatible materials, holding a total of 4 patents. His work focuses on developing innovative solutions for medical applications, particularly in the area of implantable materials.

Latest Patents

Ollila's latest patents include an "Implantable Paste and Its Use," which describes a unique composition comprising bioactive glass powder and various molecular weight polyethylene glycols. This invention aims to enhance the biocompatibility and effectiveness of implantable materials. Another significant patent is for "Resorbable and Biocompatible Fibre Glass Compositions and Their Uses," which details the creation of biocompatible glass fibers that can be used in medical devices. These compositions are designed to be resorbable, ensuring that they can safely integrate into the body.

Career Highlights

Throughout his career, Fredrik Ollila has worked with several prominent companies, including Purac Biochem Bv and Bonalive Biomaterials Oy. His experience in these organizations has allowed him to refine his expertise in biocompatible materials and contribute to groundbreaking innovations in the medical field.

Collaborations

Ollila has collaborated with notable professionals in his field, including Timo Lehtonen and Jukka Tuominen. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in biocompatible technologies.

Conclusion

Fredrik Ollila's contributions to the field of biocompatible materials are noteworthy, as evidenced by his patents and collaborations. His innovative work continues to impact the medical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…